Sign Out
Each mL contains 20 mg daratumumab.
5 mL vial: Each single-use vial contains 100 mg daratumumab.
20 mL vial: Each single-use vial contains 400 mg daratumumab.
Daratumumab is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody against CD38 antigen, produced in a mammalian cell line (Chinese Hamster Ovary [CHO]) using recombinant DNA technology.
Daratumumab (Darzalex) is available as a colorless to yellow preservative free liquid concentrate for intravenous infusion after dilution.
Excipients/Inactive ingredients: The excipients are glacial acetic acid, mannitol, polysorbate 20, sodium acetate trihydrate, sodium chloride and water for injection.
